AKBA Akebia Therapeutics, Inc.

$0.95▲ +0.55% Healthcare Other
After hours $0.95▲ +0.03% Sep 11, 7:33 PM ET
Volume 6.14M Avg Volume (10D) 9.26M
Key Metrics & Fundamentals
Market Cap
$263.72M
P/E Ratio
–
Div Yield
–%
52W Range
0.81 - 3.20
% vs 50 MA
-14.47%
% vs 200 MA
-25.74%
RSI-14
46.1
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.14
Free Cash Flow
-$554,000
Gross Rev
$49.13M
Gross Profit
$38.70M
EBITDA
-$3.80M
COGS
$10.42M
Operating Exp
$43.09M
Operating Income
-$4.38M
EBIT
-$4.38M
Pretax Income
-$8.84M
Net Income
-$8.91M
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 1, 2026 8:05 PM
Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston
GlobeNewswire · Sep 1, 2026 12:00 PM
Akebia Therapeutics Inc (AKBA) (Q2 2026) Earnings Call Highlights: Vafseo Surges 60% as VOICE ...
GuruFocus.com · Aug 6, 2026 5:10 AM
Akebia Therapeutics (AKBA) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 5, 2026 10:10 PM
Akebia Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 5, 2026 10:03 PM
Akebia Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 9:04 PM
Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
GlobeNewswire · Aug 5, 2026 8:05 PM
Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases
GlobeNewswire · Aug 3, 2026 12:00 PM
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
GlobeNewswire · Jul 29, 2026 12:00 PM
Akebia Therapeutics, Inc. (AKBA) Strengthens Vafseo Patent Protection Through 2036
Insider Monkey · Jun 30, 2026 1:10 PM
Financial Overview - Income Statement Quarterly

See AKBA's money flow as a full page

Social Sentiment
Avg +0.15 · 2 posts
DDNewsEarningsTradePriceTarget$AKBA was professionally pumped, diluted and dumped
r/wallstreetbets · Mar 20, 2025
The post alleges manipulation, dilution, and potential legal issues, expressing significant concern about the stock's future.
negative -0.60
NewsDiscussionPriceTarget$AKBA is saving me! billion dollar drug launch Jan 1st… i just like it 🥹
r/wallstreetbets · Nov 20, 2024
The user states 'AKBA is saving me!' and expresses positive sentiment about the company's drug launch.
very_positive +0.90
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙